Manufacturing

Articles

The new program, Cornerstone, integrates process development expertise and novel technology to remove development bottlenecks in the manufacture of gene therapy medicinal products.

BIA Separations Launches AAV Process Development Service to Accelerate Gene Therapy Production

The venture will focus on single-use and modular systems designed to develop novel biotherapeutics.

GE and Germfree Collaborate on Modular Manufacturing

TrakCel and McKesson have formed a collaboration that is aimed at accelerating commercialization of cell and gene therapies by leveraging services to enable a more efficient development pathway.

Collaboration Aims to Drive Commercialization of Next-Generation Therapies

The companies plan to create a new curriculum focusing on single-use applications training, cell therapy technology, process efficiency strategies, process development methodologies, and chromatography proficiency.

GE Healthcare to Partner with NIBRT for Biopharma Education Program

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Innovation in manufacturing technologies must occur to ensure the availability of gene therapies and cell therapies.

Seeking Solutions for Large-Scale GMP Viral Vector Manufacturing

Innovate UK has awarded a grant worth thousands to the Atelerix Consortium for the collaborative work with the Cell and Gene Therapy Catapult and Rexgenero on development of cell stabilization technology.

Innovate UK Awards Thousands for Development of Cell Stabilization Technologies

Pfizer is investing $500 million for the construction of a state-of-the-art gene therapy manufacturing facility in Sanford, NC.

Pfizer Invests $500 Million into Its Gene Therapy Facility

The companies have entered into a manufacturing agreement for the production of Phase III clinical trial material.

Caladrius Biosciences, Cognate BioServices in Clinical Manufacturing Pact

AskBio’s acquisition of Synpromics will improve the efficacy of its adeno-associated virus gene therapy vectors.

AskBio Plans to Improve Gene Therapeutics with Synpromics Acquisition

The acquisition strengthens BioLife’s position as a supplier of disruptive, enabling solutions used for manufacturing, storage, and distribution of cell and gene therapies.

Manufacturing, Cell Therapies